Marstacimab for the Treatment of Hemophilia A or B
Hemophilia A and B, caused by deficiencies of coagulation factors VIII or IX, result in impaired thrombin generation with consequent spontaneous or trauma-related bleeding, particularly hemarthroses. Although prophylactic factor replacement therapy remains the global standard of care for hemophilia, it has significant limitations, including intravenous
openaire +4 more sources
Molecular diagnosis of hemophilia A and B. Report of five families from Costa Rica
Hemophilia Aand B are X-chromosome linked bleeding disorders caused by deficiency of the respective coagulation factor VIII and IX. Affected individuals develop a variable phenotype of hemorrhage caused by a broad range of mutations within the Factor ...
Lizbeth Salazar-Sánchez +8 more
doaj
Hemophilia B is factor IX deficiency and is inherited as X-linked recessive disorder. The subject of carrier detection in hemophilias has received new impetus in the last several years.
P Ghandil +3 more
doaj
Doing more with less in hemophilia B gene therapy. [PDF]
Miesbach W.
europepmc +1 more source
Stereotactic electroencephalogram lead placement in patient with hemophilia B: illustrative case. [PDF]
Lee GA +4 more
europepmc +1 more source
Occult Hemophilia B and Plastic Surgery: Preventing Bleeding Events. [PDF]
Cárdenas-Camarena L +2 more
europepmc +1 more source
Evaluation of the completeness of a medical record dataset linked to administrative claims through tokenization in patients with Hemophilia B. [PDF]
Kane AS, Stan DM, Jeng D, Chen Y.
europepmc +1 more source
Case Report: Atypical presentations of neonatal and infantile hemophilia B. [PDF]
Locke A +6 more
europepmc +1 more source
Six-year FIX-padua gene therapy in hemophilia B. [PDF]
Miesbach W, Herzog R.
europepmc +1 more source
Extravascular distribution of factor IX-review of experimental and clinical evidence, and relevance for hemophilia B replacement therapy. [PDF]
Hermans C +6 more
europepmc +1 more source

